Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Efficacy and tolerance of ruxolitinib in refractory sclerodermatous chronic graft‐versus‐host disease

Published:2017-10-22 Issue:5 Volume:177 Page:
ISSN:0007-0963
Container-title:British Journal of Dermatology
language:en
Short-container-title:Br J Dermatol

Author:

Hurabielle C.¹^ORCID,Sicre de Fontbrune F.²,Moins‐Teisserenc H.³⁴,Robin M.²,Jachiet M.¹,Coman T.²,Dhedin N.²,Cassius C.¹^ORCID,Chasset F.¹,Masson A.¹,Michonneau D.²,Bagot M.¹⁴,Bergeron A.⁴⁵,Socié G.²⁴,Peffault de Latour R.²⁴,Bouaziz J.‐D.¹⁴^ORCID

Affiliation:

1. Service de Dermatologie AP‐HP Hôpital Saint‐Louis Paris 75010 France

2. Service d'Hématologie AP‐HP Hôpital Saint‐Louis Paris 75010 France

3. Service d'Immunobiologie AP‐HP Hôpital Saint‐Louis Paris 75010 France

4. Université Paris Diderot‐Paris VII Sorbonne Paris Cité Paris France

5. Service de Pneumologie AP‐HP Hôpital Saint‐Louis Paris 75010 France

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/bjd.15593

Reference8 articles.

1. Consensus Conference on Clinical Practice in Chronic GVHD: Second-Line Treatment of Chronic Graft-versus-Host Disease

2. Ruxolitinib in corticosteroid-refractory graft-versus-host disease after allogeneic stem cell transplantation: a multicenter survey

3. Incidence, risk factors, and outcomes of sclerosis in patients with chronic graft-versus-host disease

4. Sclerotic-type chronic GVHD of the skin: clinical risk factors, laboratory markers, and burden of disease

5. National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: I. The 2014 Diagnosis and Staging Working Group Report

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ERS/EBMT clinical practice guidelines on treatment of pulmonary chronic graft-versus-host disease in adults;European Respiratory Journal;2024-03

2. Enfermedad injerto contra receptor crónica: revisión sistemática de la afectación articular y fascial;Reumatología Clínica;2023-05

3. Chronic graft-versus-recipient disease: Systematic review of joint and fascial involvement;Reumatología Clínica (English Edition);2023-05

4. JAK1/2 Inhibitor Baricitinib Improves Skin Fibrosis and Digital Ulcers in Systemic Sclerosis;Frontiers in Medicine;2022-06-06

5. Janus kinase inhibitors for treatment of morphea and systemic sclerosis: A literature review;Dermatologic Therapy;2022-03-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3